TIMI 9B compared the efficacy of a lower dose of intravenous hirudin to unfractionated heparin as adjunctive therapy to fibrinolysis and aspirin among patients presenting with ST elevation myocardial infarction.
Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial
Circulation. 1996 Sep 1;94(5):911-21.
Hirudin: Its Biology and Clinical Use. J Thromb Thrombolysis. 1994;1(1):7-16.
Hirudin in Acute Myocardial Infarction. J Thromb Thrombolysis. 1995;1(3):259-267.
Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty. J Am Coll Cardiol. 1995 Jun;25(7 Suppl):30S-37S.
Trials and tribulations of thrombin inhibition. Eur Heart J. 1996 Jul;17(7):971-3.
Reexamination of the Thrombin Hypothesis: What We Have Learned from TIMI 9B and GUSTO IIb. J Thromb Thrombolysis. 1997;4(3/4):321-323.
Another chapter of the antithrombin story has been written. Eur Heart J. 1997 Sep;18(9):1365-7.
Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation. 1998 Mar 24;97(11):1042-5.
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. J Am Coll Cardiol. 1999 Feb;33(2):479-87.
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage. Am Heart J. 2001 May;141(5):742-50.
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients’ data. Lancet. 2002 Jan 26;359(9303):294-302.
Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). J Thromb Thrombolysis. 2006 Apr;21(2):119-29.